Gemcitabine combined with cisplatin as adjuvant chemotherapy for non‐small cell lung cancer: A retrospective analysis
Sign Up to like & getrecommendations! Published in 2017 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.12472
Abstract: This study was conducted to evaluate the value of gemcitabine combined with cisplatin as adjuvant chemotherapy for radical resection of non‐small cell lung cancer. read more here.
Keywords: adjuvant chemotherapy; cisplatin adjuvant; combined cisplatin; gemcitabine combined ... See more keywords
Modelling an evaluation of the efficacy and safety of gemcitabine combined with platinum in the treatment of non‐small cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13632
Abstract: Gemcitabine combined with platinum is currently the recommended first‐line chemotherapy for advanced non‐small cell lung cancer (NSCLC). This study aimed to quantitatively compare the efficacy and safety of gemcitabine‐platinum combinations in the treatment of advanced… read more here.
Keywords: non small; combined platinum; small cell; gemcitabine combined ... See more keywords
Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-116600
Abstract: Objective: To explore the clinical efficacy and adverse reactions of gemcitabine combined with cyclophosphamide, vinblastine and prednisolone (GCVP regiments) in the treatment of relapse and/or refractory non-hodgkin's lymphoma (NHL) in adults patients. Methods: 27 relapse… read more here.
Keywords: lymphoma; adverse reactions; efficacy; vinblastine ... See more keywords
The open, multicenters, double-arms, randomized, parallel controlled clinical trial of lobaplatin or gemcitabine combined with docetaxel as second-line therapy for advanced osteosarcoma-the effectiveness and safety analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e22506
Abstract: e22506Background: to study the progression free survival (PFS), objective response rate (ORR), overall survival (OS) and safety of lobaplatin or gemcitabine combined with docetaxel as second-line t... read more here.
Keywords: lobaplatin gemcitabine; combined docetaxel; docetaxel second; safety ... See more keywords
Clinical efficacy of intravesical gemcitabine combined with ubenimex in patients with non-muscle-invasive bladder carcinoma after transurethral resection of bladder tumor
Sign Up to like & getrecommendations! Published in 2022 at "Pakistan Journal of Medical Sciences"
DOI: 10.12669/pjms.38.5.4599
Abstract: Objectives: To evaluate the clinical value of intravesical gemcitabine combined with immunotherapy in patients with non-muscle-invasive bladder carcinoma (NMIBC) after transurethral resection of bladder tumor (TURBT). Methods: Eighty patients with non-muscle-invasive urothelial carcinoma treated in… read more here.
Keywords: bladder; group; gemcitabine combined; control group ... See more keywords